Sponsor
Gayle Gordillo
Status
Terminated
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04020419
This is a prospective, randomized, double-blind, placebo-controlled parallel group study evaluating the use of PediaBerry for the treatment of hemangiomas in infants ≤ 4 months of corrected gestation age over a 6-month treatment period. Subjects will be followed to age 18 months. A total of 44 subjects will be PediaBerry group and 22 subjects in the placebo control group.
Intervention
PediaBerry
Condition
Hemangioma
Investigators
Gayle Gordillo, MD